Structure of the CheY-binding domain of histidine kinase CheA in complex with CheY.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 9437425)

Published in Nat Struct Biol on January 01, 1998

Authors

M Welch1, N Chinardet, L Mourey, C Birck, J P Samama

Author Affiliations

1: Institut de Pharmacologie et de Biologie Structurale CNRS, UPR9062, Toulouse, France.

Articles citing this

Structure and function from the circadian clock protein KaiA of Synechococcus elongatus: a potential clock input mechanism. Proc Natl Acad Sci U S A (2002) 3.47

How signals are heard during bacterial chemotaxis: protein-protein interactions in sensory signal propagation. J Bacteriol (2000) 2.76

Three-dimensional structure and organization of a receptor/signaling complex. Proc Natl Acad Sci U S A (2004) 1.65

Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother (1999) 1.57

Conformational coupling in the chemotaxis response regulator CheY. Proc Natl Acad Sci U S A (2001) 1.53

Structure of the ternary complex formed by a chemotaxis receptor signaling domain, the CheA histidine kinase, and the coupling protein CheW as determined by pulsed dipolar ESR spectroscopy. Biochemistry (2010) 1.49

Crystal structure of the response regulator 02 receiver domain, the essential YycF two-component system of Streptococcus pneumoniae in both complexed and native states. J Bacteriol (2004) 1.36

Two binding modes reveal flexibility in kinase/response regulator interactions in the bacterial chemotaxis pathway. Proc Natl Acad Sci U S A (1998) 1.27

The crystal structure of the phosphorylation domain in PhoP reveals a functional tandem association mediated by an asymmetric interface. J Bacteriol (2003) 1.27

Conformational changes of Spo0F along the phosphotransfer pathway. J Bacteriol (2005) 1.21

In different organisms, the mode of interaction between two signaling proteins is not necessarily conserved. Proc Natl Acad Sci U S A (2004) 1.18

Crystal structures of beryllium fluoride-free and beryllium fluoride-bound CheY in complex with the conserved C-terminal peptide of CheZ reveal dual binding modes specific to CheY conformation. J Mol Biol (2006) 1.14

Self-assembly of receptor/signaling complexes in bacterial chemotaxis. Proc Natl Acad Sci U S A (2006) 1.13

The structure of a cyanobacterial sucrose-phosphatase reveals the sugar tongs that release free sucrose in the cell. Plant Cell (2005) 1.11

Protein-protein interactions as a tool for site-specific labeling of proteins. Protein Sci (2005) 1.07

The 3.2 Å resolution structure of a receptor: CheA:CheW signaling complex defines overlapping binding sites and key residue interactions within bacterial chemosensory arrays. Biochemistry (2013) 1.05

Crystal structure of a phosphatase with a unique substrate binding domain from Thermotoga maritima. Protein Sci (2003) 1.04

Different evolutionary constraints on chemotaxis proteins CheW and CheY revealed by heterologous expression studies and protein sequence analysis. J Bacteriol (2003) 0.96

Crystal structures of two cyanobacterial response regulators in apo- and phosphorylated form reveal a novel dimerization motif of phytochrome-associated response regulators. Biophys J (2004) 0.95

Crystal structure of trehalose-6-phosphate phosphatase-related protein: biochemical and biological implications. Protein Sci (2006) 0.94

Defining a key receptor-CheA kinase contact and elucidating its function in the membrane-bound bacterial chemosensory array: a disulfide mapping and TAM-IDS Study. Biochemistry (2013) 0.94

The phosphoryl transfer domain of UhpB interacts with the response regulator UhpA. J Bacteriol (2001) 0.92

Genetic analysis of response regulator activation in bacterial chemotaxis suggests an intermolecular mechanism. Protein Sci (2002) 0.89

The histidine kinase domain of UhpB inhibits UhpA action at the Escherichia coli uhpT promoter. J Bacteriol (2000) 0.84

Solution structure of a complex of the histidine autokinase CheA with its substrate CheY. Biochemistry (2012) 0.84

The two active sites of Thermotoga maritima CheA dimers bind ATP with dramatically different affinities. Biochemistry (2009) 0.83

NMR studies of the sporulation protein SpoIIAA: implications for the regulation of the transcription factor sigmaF in Bacillus subtilis. J Biomol NMR (2001) 0.83

Identification of an anchor residue for CheA-CheY interactions in the chemotaxis system of Escherichia coli. J Bacteriol (2011) 0.80

Purification, crystallization and preliminary X-ray diffraction analysis of human enolase-phosphatase E1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.76

Structural insight into the low affinity between Thermotoga maritima CheA and CheB compared to their Escherichia coli/Salmonella typhimurium counterparts. Int J Biol Macromol (2011) 0.75

Involvement of two-component signaling in bacterial motility and biofilm development. J Bacteriol (2017) 0.75

Articles by these authors

Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 A resolution. Proteins (1993) 3.70

Conformational changes induced by phosphorylation of the FixJ receiver domain. Structure (1999) 2.22

Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases. Proc Natl Acad Sci U S A (2001) 2.21

Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis. J Biol Chem (1992) 2.03

Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa. Structure (2000) 1.84

X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity. J Biol Chem (1998) 1.69

Crystallographic investigations of nicotinamide adenine dinucleotide binding to horse liver alcohol dehydrogenase. Biochemistry (1984) 1.68

Beta-lactamase TEM1 of E. coli. Crystal structure determination at 2.5 A resolution. FEBS Lett (1992) 1.59

Staphylococcal pore-forming toxins. Curr Top Microbiol Immunol (2001) 1.55

The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure (1999) 1.45

Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem J (1995) 1.38

X-ray studies of the binding of Cibacron blue F3GA to liver alcohol dehydrogenase. Eur J Biochem (1979) 1.35

The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34

Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol (2001) 1.33

The high resolution crystal structure for class A beta-lactamase PER-1 reveals the bases for its increase in breadth of activity. J Biol Chem (2000) 1.32

Crystal structure of the CheA histidine phosphotransfer domain that mediates response regulator phosphorylation in bacterial chemotaxis. J Biol Chem (2001) 1.25

Binding of substrate in a ternary complex of horse liver alcohol dehydrogenase. J Biol Chem (1982) 1.16

Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs. FEBS Lett (1999) 1.11

Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases. Biochemistry (1998) 1.09

The molecular puzzle of two-component signaling cascades. Microbes Infect (2001) 1.09

The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to clavulanic acid. J Biol Chem (1995) 1.08

Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. J Mol Biol (1993) 1.08

Synergistic transcriptional activation by TATA-binding protein and hTAFII28 requires specific amino acids of the hTAFII28 histone fold. Mol Cell Biol (1999) 1.04

Electrostatic analysis of TEM1 beta-lactamase: effect of substrate binding, steep potential gradients and consequences of site-directed mutations. Structure (1995) 1.03

Pyrazole binding in crystalline binary and ternary complexes with liver alcohol dehydrogenase. Biochemistry (1982) 1.03

Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci (2000) 1.01

Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant. Biochemistry (1995) 1.01

X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid. Biochemistry (1999) 1.00

6-(hydroxyalkyl)penicillanates as probes for mechanisms of beta-lactamases. J Antibiot (Tokyo) (2000) 0.97

Structural transitions in the FixJ receiver domain. Structure (1999) 0.97

Structural basis of extended spectrum TEM beta-lactamases. Crystallographic, kinetic, and mass spectrometric investigations of enzyme mutants. J Biol Chem (1996) 0.96

Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes. Eur J Biochem (1993) 0.96

Crystal structure determinations of coenzyme analogue and substrate complexes of liver alcohol dehydrogenase: binding of 1,4,5,6-tetrahydronicotinamide adenine dinucleotide and trans-4-(N,N-dimethylamino)cinnamaldehyde to the enzyme. Biochemistry (1982) 0.92

Cardiotoxin VII4 from Naja mossambica mossambica. The refined crystal structure. J Mol Biol (1990) 0.91

Further insights into the mechanism of function of the response regulator CheY from crystallographic studies of the CheY--CheA(124--257) complex. Acta Crystallogr D Biol Crystallogr (2001) 0.91

Characterization and sugar-binding properties of arcelin-1, an insecticidal lectin-like protein isolated from kidney bean (Phaseolus vulgaris L. cv. RAZ-2) seeds. Biochem J (1998) 0.88

Crystal structure of a snake venom cardiotoxin. Proc Natl Acad Sci U S A (1987) 0.86

Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients. Hum Pathol (2001) 0.86

Inhibition of the broad spectrum nonmetallocarbapenamase of class A (NMC-A) beta-lactamase from Enterobacter cloacae by monocyclic beta-lactams. J Biol Chem (1999) 0.84

Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin. Vaccine (1990) 0.84

Antithrombin III: structural and functional aspects. Biochimie (1990) 0.84

Crystal structure of the F component of the Panton-Valentine leucocidin. Int J Med Microbiol (2000) 0.84

Is the function of the cdc2 kinase subunit proteins tuned by their propensities to oligomerize? Conformational states in solution of the cdc2 kinase partners p13suc1 and p9cksphy. Biochemistry (1996) 0.83

The crystal structure of complexes between horse liver alcohol dehydrogenase and the coenzyme analogues 3-iodopyridine-adenine dinucleotide and pyridine-adenine dinucleotide. Eur J Biochem (1977) 0.83

Enzymes and microemulsions. Activity and kinetic properties of liver alcohol dehydrogenase in ionic water-in-oil microemulsions. Eur J Biochem (1987) 0.81

Crystallization and preliminary crystallographic data on Escherichia coli TEM1 beta-lactamase. J Mol Biol (1992) 0.81

Preparation and properties of 3-halopyridine--adenine dinucleotides, NAD+ analogues and model compounds. Eur J Biochem (1976) 0.80

Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases. J Eur Acad Dermatol Venereol (2011) 0.80

An investigation of the active site of lactate dehydrogenase with NAD+ analogues. Eur J Biochem (1981) 0.79

High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells. Biochem Pharmacol (1992) 0.78

Oligomerization state in solution of the cell cycle regulators p13suc1 from the fission yeast and p9cksphy from the myxomycete Physarum, two members of the cks family. FEBS Lett (1995) 0.77

Oligomeric structure of the repressor of the bacteriophage Mu early operon. Eur J Biochem (1998) 0.77

Characterisation of human cdc2 lysine 33 mutations expressed in the fission yeast Schizosaccharomyces pombe. FEBS Lett (1996) 0.77

Body Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review. J Nutr Health Aging (2016) 0.76

Crystal structure of the arcelin-1 dimer from Phaseolus vulgaris at 1.9-A resolution. J Biol Chem (1998) 0.76

Functional and structural analysis of the subunits of human transcription factor TFIID. Cold Spring Harb Symp Quant Biol (1998) 0.76

5-Methylnicotinamide-adenine dinucleotide. Kinetic investigation with major and minor isoenzymes of liver alcohol dehydrogenase and structural determination of its binary complex with alcohol dehydrogenase. Eur J Biochem (1981) 0.75

Crystallization and preliminary X-ray study of pig lens aldose reductase. J Mol Biol (1987) 0.75

Small-angle X-ray scattering and crystallographic studies of arcelin-1: an insecticidal lectin-like glycoprotein from Phaseolus vulgaris L. Proteins (1997) 0.75

Properties of 3-aldoxime pyridine adenine dinucleotide, an NAD+ analogue. Biochimie (1973) 0.75

Crystallization and preliminary crystallographic data for bovine antithrombin III. J Mol Biol (1989) 0.75

[Mood and cognitive disorders, and androgen deprivation]. Prog Urol (2012) 0.75

Pig lens aldose reductase: purification and preliminary X-ray diffraction study. Oligomerization of the enzyme. Prog Clin Biol Res (1987) 0.75

Dependence of the substrate specificity and kinetic mechanism of horse-liver alcohol dehydrogenase on the size of the C-3 pyridinium substituent. 3-Benzoylpyridine-adenine dinucleotide. Eur J Biochem (1986) 0.75